Jitendra Sriram

CNBC-TV18's Sonia Shenoy and Anuj Singhal spoke to a panel of guests on their expectations from first quarter earnings. They gave their views and outlook on a range of sectors from cement, capital goods to pharma. Here are their views.

Underweight on India despite 10% correction since May: HSBC

"Despite the market, in dollar terms, correcting nearly 10 percent since May, we remain underweight on India," Jitendra Sriram, HSBC said.

Sensex yr-end target 26900; cherry-pick pvt banks too: HSBC

HSBC's Jitendra Sriram, says Maruti Suzuki can post a decent upside from its current levels. A weaker yen and its foray into other interesting space will take the stock to Rs 6000 levels in the next two years, he adds.

More downside if monsoon disappoints; like telecom: HSBC

Sriram said he was bullish on telecom stocks as earnings were beginning to stabilise and the spread of smart phones was rising

Pick Voltas, UPL: Jitendra Sriram

Jitendra Sriram, MD & Head-Research of HSBC India is of the view that one may pick Voltas and UPL from the midcap space.

Jitendra Sriram positive on NTPC

Jitendra Sriram, MD & Head-Research of HSBC India has a positive view on NTPC.

HDFC Bank, IDFC top picks: Jitendra Sriram

Jitendra Sriram, MD & Head-Research of HSBC India is overweight on private banks and has top picks in the space including HDFC Bank and IDFC.

Prefer Infosys, Sun Pharmaceutical: Jitendra Sriram

Jitendra Sriram, MD & Head-Research of HSBC India prefers Infosys and Sun Pharmaceutical Industries.

Year-end Sensex target 30100; earnings critical: HSBC India

Jitendra Sriram, MD and head of research at HSBC India says earnings season so far has been reasonable, barring a few hiccups in IT. He prefers domestic cyclicals to defensives.

Late sell-off drags Sensex 152 pts; Bank Nifty down 386 pts

The market shed all its gains in last hour of trade on Thursday, dragged by profit booking in banks, FMCG, auto and capital goods stocks. However, the Sensex had surged over 350 points intraday following a dovish statement from the US Federal Reserve.

Fed move likely pushed to Sep; mkt pause to continue: HSBC

Even as the US Federal Reserve overnight stayed away from saying it would be ‘patient‘ in raising interest rates for the first time in eight years, it said economic conditions were deteriorating a bit.

See 50 bps rate cut, good equity returns in'15: HSBC India

Jitendra Sriram, MD & Head of Research at HSBC India expects a 50 basis points rate cut by RBI through the year.

HDFC Bank, ICICI Bank top picks: Jitendra Sriram

According to Jitendra Sriram, MD & Head of Research, HSBC India, HDFC Bank and ICICI Bank are the top picks in the private sector banking space.

Overweight on India; Sensex target of 30000 for CY15: HSBC

Jitendra Sriram of HSBC says they are overweight on India with Sensex target of 30,000 for CY15.

Industrial recovery still away; like construction: HSBC

Jitendra Sriram believes the inventory levels in housing market continue to remain high and therefore, it is too early to play realty as a setoral theme.

Interact with CNBC-TV18: Prefer selective IT stocks now; like TCS: HSBC

According to Jitendra Sriram, a lot has to do with the fact that where market was seeing currency at levels of 58-59/USD we have probably moved up to about 61/USD right now

Neutral on India as good news discounted; like Voltas: HSBC

Sriram says it will take another 2-3 quarters for corporate earnings to pick up. He is turning positive on domestic industrials and is selective on IT and tech plays.

Interact with CNBC-TV18: Would look at infra selectively says HSBC India's Sriram

Jitendra Sriram MD & Head of Research HSBC India said there are certain pockets in infrastructure which look a bit more active than the others but there does not seem too much fiscal room for funding projects.

Underweight on India, fund flow disconnect a worry: HSBC

Jitendra Sriram, MD & Head of Research, HSBC India says the EPFR data for India seems to suggests an outflow of almost USD 3 billion year-to-date while SEBI data shows an inflow of about USD 1.2 billion. So there is a disconnect.

See immediate resistance for Nifty at 6190: JM Financial

Gautam Shah, JM Financial feels there is immediate resistance around 6190 on the Nifty. “Only on a close above 6190 do the bulls have some of the control taking the index towards 6270-6300,” he adds.

Jitendra Sriram overweight on L&T, IL&FS Engineering

Jitendra Sriram, MD & Head of Research at HSBC India is overweight on Larsen and Toubro and ILandFS Engineering.

Not bullish on mkt, yr-end Sensex target at 20250: HSBC

Street‘s estimate of 15 percent FY15 earnings growth is over optimistic, says Jitendra Sriram, MD & Head of Research, HSBC India.

Prefer Sun Pharmaceutical, Lupin: Jitendra Sriram

Jitendra Sriram, MD & Head of Research of HSBC India is of the view that one may prefer Sun Pharmaceutical and Lupin from the pharma space.

Prefer TCS in IT space: Jitendra Sriram

According to Jitendra Sriram, MD & Head of Research of HSBC India, one may prefer Tata Consultancy Services (TCS) in the IT space.

Maintain year-end Sensex target of 20700: HSBC

Within the EM space, India is still finding some favour, says Jitendra Sriram, MD & Head of Research, HSBC India.